C A Knupp

632 total citations
19 papers, 527 citations indexed

About

C A Knupp is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, C A Knupp has authored 19 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in C A Knupp's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (4 papers). C A Knupp is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV Research and Treatment (4 papers). C A Knupp collaborates with scholars based in United States, Germany and Netherlands. C A Knupp's co-authors include Rashmi H. Barbhaiya, Kelly Pittman, S. Thomas Forgue, R. Russell Martin, D.J. Weidler, Carol Gleason, James H. Tenney, C. McLaren, M Pfeffer and S. P. Swanson and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C A Knupp

19 papers receiving 493 citations

Peers

C A Knupp
Catherine A. Knupp United States
Goutam C. Mistry United States
Sean N. Avedissian United States
Kajal Larson United States
Scott A. Van Wart United States
Catherine A. Knupp United States
C A Knupp
Citations per year, relative to C A Knupp C A Knupp (= 1×) peers Catherine A. Knupp

Countries citing papers authored by C A Knupp

Since Specialization
Citations

This map shows the geographic impact of C A Knupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A Knupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A Knupp more than expected).

Fields of papers citing papers by C A Knupp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C A Knupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A Knupp. The network helps show where C A Knupp may publish in the future.

Co-authorship network of co-authors of C A Knupp

This figure shows the co-authorship network connecting the top 25 collaborators of C A Knupp. A scholar is included among the top collaborators of C A Knupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C A Knupp. C A Knupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Abreu, Thalita Fernandes de, Karen I. Plaisance, Vivian Rexroad, et al.. (2000). Bioavailability of Once- and Twice-Daily Regimens of Didanosine in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 44(5). 1375–1376. 5 indexed citations
3.
Srinivas, Nuggehally R., C A Knupp, Byron E. Batteiger, R A Smith, & Rashmi H. Barbhaiya. (1996). A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients. British Journal of Clinical Pharmacology. 41(3). 207–215. 10 indexed citations
4.
Warner, William, Carla L. Bregman, Joseph C. Arezzo, et al.. (1995). Didanosine (ddl) and stavudine (d4T): Absence of peripheral neurotoxicity in rabbits. Food and Chemical Toxicology. 33(12). 1047–1050. 12 indexed citations
5.
Grasela, Thaddeus H., Mohan Beltangady, C A Knupp, et al.. (1994). Analysis of Potential Risk Factors Associated with the Development of Pancreatitis in Phase I Patients with AIDS or AIDS-Related Complex Receiving Didanosine. The Journal of Infectious Diseases. 169(6). 1250–1255. 21 indexed citations
6.
Knupp, C A, et al.. (1993). Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients. European Journal of Clinical Pharmacology. 45(5). 409–413. 13 indexed citations
7.
Kieft, Hans, Andy I. M. Hoepelman, C A Knupp, et al.. (1993). Pharmacokinetics of cefepime in patients with the sepsis syndrome. Journal of Antimicrobial Chemotherapy. 32(suppl B). 117–122. 37 indexed citations
8.
Knupp, C A, Francesco Graziano, Ross Dixon, & Rashmi H. Barbhaiya. (1992). Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus. Antimicrobial Agents and Chemotherapy. 36(10). 2075–2079. 20 indexed citations
9.
Barbhaiya, Rashmi H., S. Thomas Forgue, Carol Gleason, et al.. (1992). Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrobial Agents and Chemotherapy. 36(3). 552–557. 110 indexed citations
10.
Barbhaiya, Rashmi H., C A Knupp, M Pfeffer, et al.. (1992). Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 36(7). 1387–1391. 26 indexed citations
11.
Barbhaiya, Rashmi H., C A Knupp, M Pfeffer, & Kelly Pittman. (1992). Lack of pharmacokinetic interaction between cefepime and amikacin in humans. Antimicrobial Agents and Chemotherapy. 36(7). 1382–1386. 18 indexed citations
12.
Barbhaiya, Rashmi H., C A Knupp, & Kelly Pittman. (1992). Effects of age and gender on pharmacokinetics of cefepime. Antimicrobial Agents and Chemotherapy. 36(6). 1181–1185. 41 indexed citations
13.
Kaul, Sanjeev, et al.. (1991). Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs. Antimicrobial Agents and Chemotherapy. 35(4). 610–614. 5 indexed citations
14.
Barbhaiya, Rashmi H., C A Knupp, S. Thomas Forgue, et al.. (1991). Disposition of the cephalosporin cefepime in normal and renally impaired subjects.. Drug Metabolism and Disposition. 19(1). 68–73. 45 indexed citations
15.
McLaren, C., et al.. (1991). Didanosine. Antiviral chemistry & chemotherapy. 2(6). 321–328. 17 indexed citations
16.
Rozencweig, Marcel, C. McLaren, Mohan Beltangady, et al.. (1990). Overview of Phase I Trials of 2′,3′-Dideoxyinosine (ddI) Conducted on Adult Patients. Clinical Infectious Diseases. 12(Supplement_5). S570–S575. 49 indexed citations
17.
Barbhaiya, Rashmi H., S. Thomas Forgue, Carol Gleason, et al.. (1990). Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Antimicrobial Agents and Chemotherapy. 34(6). 1118–1122. 64 indexed citations
18.
Knupp, C A, S. P. Swanson, & William B. Buck. (1987). Comparative in vitro metabolism of T-2 toxin by hepatic microsomes prepared from phenobarbital-induced or control rats, mice, rabbits and chickens. Food and Chemical Toxicology. 25(11). 859–865. 15 indexed citations
19.
Knupp, C A, David G. Corley, Michael S. Tempesta, & S. P. Swanson. (1987). Isolation and characterization of 4'-hydroxy T-2 toxin, a new metabolite of the trichothecene mycotoxin T-2.. Drug Metabolism and Disposition. 15(6). 816–820. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026